-
Product Insights
NewNet Present Value Model: Eli Lilly and Co’s DC-806
Empower your strategies with our Net Present Value Model: Eli Lilly and Co's DC-806 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – DC-806 in Plaque Psoriasis (Psoriasis Vulgaris)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DC-806 in Plaque Psoriasis (Psoriasis Vulgaris) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DC-806 in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details: S-011806 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Super DC Vaccine in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Super DC Vaccine in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Super DC Vaccine in Solid Tumor Drug Details: The...
-
Product Insights
Dc Blox DC – Douglasville New Data Center Campus – Georgia
The Dc Blox DC – Douglasville New Data Center Campus – Georgia project involves the construction of a data center campus in Douglasville, Georgia, the US. Equip yourself with the essential tools needed to make informed and profitable decisions with our Dc Blox DC – Douglasville New Data Center Campus – Georgia report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding...
-
Product Insights
NewLikelihood of Approval Analysis for Retroviridae Infections
Overview How likely is it that the drugs in Retroviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Retroviridae Infections Overview Retroviruses belong to a family of enveloped RNA viruses...
-
Product Insights
NewNet Present Value Model: DICE Therapeutics Inc’s DC-806
Empower your strategies with our Net Present Value Model: DICE Therapeutics Inc's DC-806 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Washington DC DGS Solar PV Park
Washington DC DGS Solar PV Park is a solar PV project located in Washington, United States. The project is owned by WGL Energy Systems Inc and was developed by Sol Systems LLC; WGL Energy Systems Inc. The project came online in 2018. Empower your strategies with our Washington DC DGS Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to...
-
Track & Monitor
Innovation in automotive: DC-DC converters
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s DC-DC converters segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based on...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – DEN-181 in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DEN-181 in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DEN-181 in Rheumatoid Arthritis Drug Details: DEN-181 (Rheumavax) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Collagenase Clostridium Histolyticum in Fasciitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Collagenase Clostridium Histolyticum in Fasciitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Collagenase Clostridium Histolyticum in Fasciitis Drug Details: Collagenase Clostridium histolyticum (Xiapex,...